MedTrace Logo

Identification and Analysis of Immunomodulatory Molecules in Patients With Hematologic Disorders and Healthy Volunteers

NCT00223483 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 512

Last updated 2021-07-16

No results posted yet for this study

Summary

This research study goal is to analyze the plasma and the cells that make up part of the immune system. We want to learn how the plasma and cells work. These may influence why one person will develop an infection and another will not, or why one person develops severe symptoms of a disease while others remain without symptoms.

Conditions

Interventions

GENETIC

Isolation of genomic DNA

One time blood draw

Sponsors & Collaborators

Principal Investigators

  • Cesar O Freytes, MD · The University of Texas Health Science Center at San Antonio

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-03-31
Primary Completion
2020-12-11
Completion
2021-07-14

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00223483 on ClinicalTrials.gov